DD13769A - - Google Patents

Info

Publication number
DD13769A
DD13769A DD13769DA DD13769A DD 13769 A DD13769 A DD 13769A DD 13769D A DD13769D A DD 13769DA DD 13769 A DD13769 A DD 13769A
Authority
DD
German Democratic Republic
Application number
Publication of DD13769A publication Critical patent/DD13769A/xx

Links

DD13769D DD13769A (enEXAMPLES)

Publications (1)

Publication Number Publication Date
DD13769A true DD13769A (enEXAMPLES)

Family

ID=225646

Family Applications (1)

Application Number Title Priority Date Filing Date
DD13769D DD13769A (enEXAMPLES)

Country Status (1)

Country Link
DD (1) DD13769A (enEXAMPLES)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104662007B (zh) * 2012-07-25 2018-03-16 索瓦制药公司 胱硫醚‑γ‑裂合酶(CSE)抑制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104662007B (zh) * 2012-07-25 2018-03-16 索瓦制药公司 胱硫醚‑γ‑裂合酶(CSE)抑制剂

Similar Documents

Publication Publication Date Title
AU2018200632B2 (en) Cystathionine-y-lyase (CSE) inhibitors
JP2015524807A5 (enEXAMPLES)
US11021501B2 (en) Creatine phosphate analog prodrugs, compositions and methods of use thereof
US20240276957A1 (en) Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulators
CA2954474C (en) Capsule dosage form of metoprolol succinate
DD13769A (enEXAMPLES)